Protein kinase inhibitor

Results: 181



#Item
41CALIFORNIA STATE SCIENCE FAIR 2015 PROJECT SUMMARY Name(s)  Project Number

CALIFORNIA STATE SCIENCE FAIR 2015 PROJECT SUMMARY Name(s) Project Number

Add to Reading List

Source URL: www.usc.edu

Language: English - Date: 2015-04-06 12:55:00
42Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
43

PDF Document

Add to Reading List

Source URL: us.boehringer-ingelheim.com

Language: English - Date: 2015-04-21 14:44:56
44BBRC Biochemical and Biophysical Research Communications–717 www.elsevier.com/locate/ybbrc Breakthroughs and Views

BBRC Biochemical and Biophysical Research Communications–717 www.elsevier.com/locate/ybbrc Breakthroughs and Views

Add to Reading List

Source URL: www.brimr.org

Language: English - Date: 2006-02-26 12:23:05
45New technology could speed up life-saving drug discoveries

New technology could speed up life-saving drug discoveries

Add to Reading List

Source URL: phys.org

Language: English - Date: 2015-05-03 07:43:22
46Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1085 Towards Personalized Cancer Therapy New Diagnostic Biomarkers and Radiosensitization

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1085 Towards Personalized Cancer Therapy New Diagnostic Biomarkers and Radiosensitization

Add to Reading List

Source URL: uu.diva-portal.org

Language: English - Date: 2015-04-20 01:26:33
47NoFebruary 16, 2015 Eisai Co., Ltd.  U.S. FDA APPROVES ANTICANCER AGENT LENVIMATM

NoFebruary 16, 2015 Eisai Co., Ltd. U.S. FDA APPROVES ANTICANCER AGENT LENVIMATM

Add to Reading List

Source URL: www.eisai.com

Language: English - Date: 2015-02-15 19:14:10
48BBRC Biochemical and Biophysical Research Communications–1315 www.elsevier.com/locate/ybbrc Breakthroughs and Views

BBRC Biochemical and Biophysical Research Communications–1315 www.elsevier.com/locate/ybbrc Breakthroughs and Views

Add to Reading List

Source URL: www.brimr.org

Language: English - Date: 2006-02-26 12:30:02
49PUBLIC SUMMARY DOCUMENT Product: Gefitinib, tablet, 250 mg, Iressa® Sponsor: AstraZeneca Pty Limited Date of PBAC Consideration: NovemberPurpose of Application

PUBLIC SUMMARY DOCUMENT Product: Gefitinib, tablet, 250 mg, Iressa® Sponsor: AstraZeneca Pty Limited Date of PBAC Consideration: NovemberPurpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:22
50Public Summary Document – November 2014 PBAC Meeting  7.2 AXITINIB tablets, 1 mg & 5 mg;

Public Summary Document – November 2014 PBAC Meeting 7.2 AXITINIB tablets, 1 mg & 5 mg;

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14